Kelli is a litigator and eDiscovery specialist with almost two decades of experience defending pharmaceutical and medical device companies in complex litigation. Kelli focuses her practice on commercial and complex litigation as well as government enforcement actions on a national level. She also represents clients in responding to civil and criminal investigations by federal and state governments. Kelli has extensive experience in litigation including managing complex discovery and related motion practice, witness development and deposition preparation. 
As a member of Shook’s Data and Discovery Strategies group, Kelli advises clients on a range of discovery-related issues related to preservation, collection, processing and review of documents for production and case assessment. Kelli has led large teams in document reviews including both internally as well as working with third-party vendors. She provides strategies to efficiently and effectively tackle large eDiscovery review projects. Kelli also focuses her practice on tracking relevant eDiscovery cases and technology trends to better serve her clients. In these roles, Kelli provides creative and insightful information to counsel regarding the challenges posed by the exponential growth in the eDiscovery landscape.

Kelli has led privilege teams responsible for meeting Rule 26 and Federal Rule of Evidence 502 requirements for numerous pharmaceutical and medical device companies. She has deployed artificial intelligence strategies to respond to discovery that met Federal Rule of Civil Procedure 26(g) for one of the world’s largest automotive manufacturers as well as large pharmaceutical companies.


Discovery Cases That Count, First Edition, Steering Committee and Editorial Board, The Electronic Discovery Institute, December 29, 2021.

Guide to Spoliation, Fifth Edition, Editorial Board, The Electronic Discovery Institute, December 29, 2021.